JAK3 and juvenile idiopathic arthritis: For example, tofacitinib, a JAK3-specific inhibitor, is used to treat ankylosing spondylitis (AS), rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, ulcerative colitis, polyarticular juvenile idiopathic arthritis, etc. (41).